HeartSciences Secures $1.0M PIPE from Merger Partner Fortitude at $2.43/Share

summarizeSummary

HeartSciences raised $1.0 million in a private placement from merger partner Fortitude Mining Holdings, issuing 411,522 shares at $2.43 per share. The proceeds will fund operations until the expected closing of the proposed business combination.

check_boxKey Events · Financing and Capital Events · HSCS

• PIPE Investment Closed

  On August 12, 2026, HeartSciences sold 411,522 shares to Fortitude Mining Holdings at $2.43 per share, generating gross proceeds of approximately $1.0 million.

• Pricing Based on 30-Day VWAP

  The $2.43 per share purchase price was determined by the 30 trading day volume weighted average price through August 11, 2026, representing a premium to today's stock price of $2.13.

• Fortitude Ownership Increases to 9.4%

  Following the PIPE Investment, Fortitude owns approximately 9.4% of HeartSciences' issued and outstanding common stock, up from its prior stake.

• Shares Excluded from Merger Exchange Ratio

  The shares issued in the PIPE Investment are not subject to the Exchange Ratio contemplated by the Proposed Transaction, meaning they will not be converted in the merger.

auto_awesomeAnalysis · HSCS · Crypto Assets

A $1.0 million private placement from merger partner Fortitude Mining Holdings provides HeartSciences with operating capital ahead of the pending all-stock merger. The company sold 411,522 shares at $2.43 per share, a price based on the 30-day VWAP through August 11, 2026, and these shares are excluded from the merger exchange ratio. While the financing addresses near-term cash needs, it dilutes existing shareholders by roughly 9.4% of outstanding common stock. The related-party nature of the transaction underscores the company's liquidity constraints, given its going concern warning and minimal stockholders' equity.